Navigation Links
Commercialization aim of grant supporting technology that destroys cancer cells
Date:8/13/2008

Blacksburg, Va. -- A new technology, using electric pulses to destroy cancer tissue and named by NASA Tech Briefs as one of seven key technological breakthroughs of 2007, is receiving additional support aimed at moving the procedure to the marketplace. One of its lead developers, Rafael V. Davalos, a faculty member of the Virginia TechWake Forest University School of Biomedical Engineering and Sciences (SBES), received a $240,000 grant from the Wallace H. Coulter Foundation and $25,000 from the Wake Forest Comprehensive Cancer Center.

Davalos' grant from Coulter is an Early Career Translational Research Award in Biomedical Engineering. This early career awards program provides funding for assistant professors in established biomedical engineering departments within North America. The award seeks to support biomedical research that Coulter considers promising with the goal of progressing toward commercial development.

The technology, irreversible electroporation (IRE), was invented by Davalos and Boris Rubinsky, a bioengineering professor at the University of California, Berkeley.

Electroporation is a phenomenon that increases the permeability of a cell from none to a reversible opening to an irreversible opening. With the latter, the cell will die. For decades, biologists have used reversible electroporation in laboratories to introduce drugs and genes into cells while trying to avoid irreversible electroporation. By contrast, biomedical engineers Davalos and Rubinsky are now using irreversible electroporation to target cancer cells in the body.

IRE would be a minimally invasive surgical focal-ablation technique that could remove the undesirable tissue without the use of heat such as radiation. The IRE procedure involves placing small needles near the targeted region. The needles deliver a series of low energy microsecond electric pulses to the targeted tissue and the area treated can be monitored in real time using ultra
'/>"/>

Contact: Lynn Nystrom
tansy@vt.edu
540-231-4371
Virginia Tech
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. UTMB inventions win University of Texas System commercialization awards
2. IEEE Homeland Security Conference Business Panel to feature experts on technology commercialization
3. UCs NIH grant brings technology from outer space to playgrounds
4. Seattle Childrens Hospital leads $23.7 million NIH grant to study gene repair
5. Homeland Security awards 2 grants to Rutgers for nuclear threat detection
6. NIH awards researcher $1.5 million new innovator grant for fruit-fly studies of prion proteins
7. UGA Odum School of Ecology professor receives grant to study West Nile Virus in NYC
8. Genes and environment grant funds close look at nature-nurture overlap in common diseases
9. Mustafa alAbsi Ph.D. and national team awarded major NIH grant
10. NIH awards UC $9 million grant to improve patient point-of-care technologies
11. UAB wins $5.7M neurofibromatosis grant

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...n Society says that western lowland gorillas livin... the "mother lode" of more than 125,000 gorillas d...tened by growing humans activity in the region. ,...ests adjacent to the southwest border of Lac Tl Co...t high densities of the great apes still exist in ...
(Date:11/23/2009)...the highest resolution images of peptides attachin...derstanding how biomolecules manipulate the growth...nt for kidney stones using biomolecules. , The r...on of the journal Proceedings of the National Aca...with mineral surfaces by accelerating, switching a...
(Date:11/23/2009)...dical engineer and cardiologist Tzung "John" Hsiai...stinguish cardiac emergencies requiring immediate ...s and lifestyle change. , Angiograms, images mad...the heart, offer an inside view of the interior su...aling deposits of a dangerous fatty substance call...
Breaking Biology News(10 mins):A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 3Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2Gene Therapy Brings New Muscle to Monkeys 61251 1Coffee break 3A Compound brewing new research in colon breast cancer 61247 1Coffee break 3A Compound brewing new research in colon breast cancer 61247 2Coffee break 3A Compound brewing new research in colon breast cancer 61247 3Coffee break 3A Compound brewing new research in colon breast cancer 61247 4Coffee break 3A Compound brewing new research in colon breast cancer 61247 5Coffee break 3A Compound brewing new research in colon breast cancer 61247 6Discoveries at NJIT including drug to stop brain injury receives 241 4M funding 61243 1Discoveries at NJIT including drug to stop brain injury receives 241 4M funding 61243 2
...dies against the Epstein-Barr virus, the virus tha...ely to develop multiple sclerosis 15 to 20 years l...t will appear in the June 2006 print issue of Arch...ls. , Researchers have long suspected that externa...rosis (MS), a chronic autoimmune disease that affe...
...lled statins do not appear to reduce the incidence...nalysis of previous studies in the January 4 issue...ins reduce the risk of developing cancer, the auth...w article. "Statins have been studied in numerous...olled trials for primary and secondary prevention ...
...frican sleeping sickness (trypanosomiasis). Resear...for Biotechnology (VIB) connected to the Free Univ...e against this disease. , They have coupled the h...ry specifically eliminate the infection caused by ...e mechanism is powerless. Tests on mice are alread...
Other Biology News:Big hips, big belly? It's in your genes, Joslin-led study shows 2Statins have neutral effect on risk of cancer 2A large step forward in the fight against African sleeping sickness 2
(Date:11/19/2009)...FirstCall/ -- Omeros Corporation (Nasdaq: OMER ) ...e third quarter ended September 30, 2009. For the ...rted a net loss of $3.9 million, or $1.34 per shar...2.54 per share, for the same period in 2008. For t...ny reported a net loss of $15.5 million, or $5.29 ...
(Date:11/19/2009)...-FirstCall/ -- NeoStem, Inc. (NYSE Amex: NBS ), a...er to its shareholders, discussing the Company,s a...aceuticals Holdings, Inc. (CHBP), an integrated bi...ublic of China. The merger gives NeoStem a control.... Ltd., CHBP,s primary operating subsidiary and a ...
(Date:11/19/2009)...mber 19 MONITORING FORCE GmbH,anno...Flibanserin in the,indication treatment-relevant l...for orphan drug status designation with the Europe...nesia is a complication of the mainstay,treatment ...me of those,affected, since it may be disabling fo...
(Date:11/19/2009)...ne Synthesis Companies Form International Gene Syn...ces in Risk Reduction ,Five Member Companies Rep...city , (PRWEB) November 1...synthesis companies today announced agreement that...omote biosecurity in the gene synthesis industry. ...
Breaking Biology Technology:Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4
...fficer Dr. David Gelfand to Deliver Keynote Speech... Inc. (OTC Bulletin Board: WGBS), a leading develo...g, cell biology and stem cell,research systems, to...entific officer, will deliver a keynote speech at ...Molecular Diagnostics Partnerships in,Personalized...
...Y, March 18, 2008Biotechnology companies are incre... clinical trials, reports Genetic Engineering and ...or clinical trial patients in the industrialized w...move, according to an article in the March 15 issu...em.aspx?aid=2401 ) , A ready supply of patients a...
...March 18 InterMune, Inc.,(Nasdaq: ITMN ) issued ...nt,of a former employee in connection with the pro...amma-1b) during a period that ended in June of,200...mer employee who left the,company more than four y...ment claims related to that,conduct, without crimi...
Other Biology Technology:WaferGen to Present at the Cambridge Health Institute's Fifth Annual Molecular Diagnostics Partnerships in Personalized Medicine Conference 2WaferGen to Present at the Cambridge Health Institute's Fifth Annual Molecular Diagnostics Partnerships in Personalized Medicine Conference 3Statement by InterMune, Inc. Regarding Justice Department Action Against Former Employee for Past Conduct 2Statement by InterMune, Inc. Regarding Justice Department Action Against Former Employee for Past Conduct 3
...k Accession Number : NM_002542 Immunogen : Bacter...rresponding to residues 166-223 of human AP-2&alph...lation: 0.1M Tris-glycine, pH 7.4, 0.15M NaCl, 0.0... 30% Quality Assurance: routinely evaluated by imm...
Rabbit Anti-Human Secretory Carrier Membrane Protein 2 (SCAMP2) Polyclonal Antibody, Unconjugated from Lifespan Biosciences
Mouse Anti-Mucin 3 (MUC3) Ab-2 Monoclonal Antibody, Unconjugated, Clone 1143/B7 from Lab Vision
...omeobox family, is an intestine-specific transcrip...differentiation in intestinal epithelial cells. It...ds the phenotype of differentiated villus enterocy.... Clone CDX2-88 reacts with a conserved epitope of...
Biology Products: